Search

everythinglearnresearchcommunity

for

Search:↓

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

WYE-130600 may cause skin thickening and irritation.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

A new method improves betulin delivery and shows promise in cancer treatment.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

The FDA approved a new Pfizer drug for hair loss in teens.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.